MALVERN, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for ...
Hosted on MSN
Neuronetics Gains Breakthrough as New York Medicaid Expands Coverage for TMS Depression Therapy
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced Wednesday that New York State Medicaid will begin covering transcranial magnetic stimulation (TMS) for adults with major depressive disorder ...
Moment of Clarity has published a new educational resource on insurance coverage considerations for transcranial magnetic stimulation (TMS) in the treatment of depression. The article, titled “Does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results